The Endocrinology of aging – short overview

Czech version

Authors: F. Gabalec; J. Čáp
Authors‘ workplace: IV. interní hematologická klinika LF UK a FN Hradec Králové
Published in: Kardiol Rev Int Med 2015, 17(2): 181-183
Category: Internal Medicine

Overview

Human life extension in developed countries and related social, medical and economic consequences have become a growing matter of public concern. Impaired physical and mental performance in elderly individuals is not necessarily caused by age and deserves adequate diagnosis and therapy. Endocrine causes can be missed due to comorbidities and less frequent typical symptoms. This review focuses on endocrine changes in aging.

Keywords:
endocrinology – hormones – aging

Sources

1. United Nations. Department of Economic and Social Affairs. Population Division. World Population Ageing 2013. [online] Available from: http:/ / www.un.org/ en/ development/ desa/ population/ publications/ ageing/ WorldPopulationAgeing2013.shtml.

2. Ústav zdravotnických informací a statistiky ČR. Zdravotnická ročenka České republiky 2013. [online] Dostupné z: http:/ / www.uzis.cz/ publikace/ zdravotnicka‑ rocenka‑ ceske‑ republiky‑ 2013.

3. Starka L. Endokrinologie stárnutí. Intern Med Pro Prax 2002; 6: 280– 289.

4. Boelaert K. Thyroid dysfunction in the elderly. Nat Rev Endocrinol 2013; 9: 194– 204. doi: 10.1038/ nrendo.2013.30.

5. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993; 328: 553– 559. doi: 10.1056/ NEJM199302253280807.

6. Lášticová M. Diabetes mellitus 2. typu ve stáří. Geriatrie a gerontologie 2014; 3: 88– 91.

7. Pelikánová T, Bartoš V. Praktická diabetologie. Praha: Maxdorf 2010.

8. Perrini S, Laviola L, Natalicchio A et al. Associated hormonal declines in aging: DHEAS. J Endocrinol Invest 2005; 28 (Suppl 3): 85– 93.

9. Starka L. Stárnutí u mužů a steroidní hormony 2. díl – adrenopauza. Interní medicína pro praxi 2012; 14: 257– 260.

10. Arlt W. Dehydroepiandrosterone and ageing. Best Pract Res Clin Endocrinol Metab 2004; 18: 363– 380. doi: 10.1016/ j.beem.2004.02.006.

11. Veldhuis JD, Sharma A, Roelfsema F. Age‑ dependent and gender‑ dependent regulation of hypothalamic‑adrenocorticotropic‑adrenal axis. Endocrinol Metab Clin North Am 2013; 42: 201– 225. doi: 10.1016/ j.ecl.2013.02.002.

12. Zadik Z, Chalew SA, McCarter RJ Jr et al. The influence of age on the 24- hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab 1985; 60: 513– 516. doi: 10.1210/ jcem‑ 60‑ 3‑ 513.

13. Liu H, Bravata DM, Olkin I et al. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med 2007; 146: 104– 115.

14. Junnila RK, List EO, Berryman DE et al. The GH/ IGF‑1 axis in ageing and longevity. Nat Rev Endocrinol 2013; 9: 366– 376. doi: 10.1038/ nrendo.2013.67.

15. Jones CM, Boelaert K. The endocrinology of ageing: A mini‑review. Gerontology 2014. doi: 10.1159/ 000367692.

16. Wu FC, Tajar A, Beynon JM et al. Identification of late‑ onset hypogonadism in middle‑ aged and elderly men. N Engl J Med 2010; 363: 123– 135. doi: 10.1056/ NEJMoa0911101.

17. Bhasin S, Cunningham GR, Hayes FJ et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95: 2536– 2559. doi: 10.1210/ jc.2009‑ 2354.